With the continuous technology advancement, the Point-of-Care method and 3D Printing technique also known as additive manufacturing, are getting implemented and adapted by the growing number of hospitals, medical clinics and care centers. Having an easier and more affordable access to innovative technologies, healthcare becomes much more personalized.

As the Point-Of-Care 3D Printing is being instantly developed, manufacturing surgical models,
patient-specific implants, organ prototypes or other needed facilities by this approach, is both more
efficient and beneficial. Almost 95% professionals believe that Point-of-Care manufacturing can be
expanded mainly through 3D printing. Being able to treat patients’ complex surgical cases faster and with
the significantly lower risk of an error (ex. 3D visualizations) becomes doctors highest desire.

The global market of 3D Printing appears to rapidly grow and is expected to generate $2.34 Billions
Dollars revenue by 2024 , but there are still a lot of regulations to be considered. The US regulations
regarding point-of-care 3D printing are not accurate enough yet, however research and development is in
progress while the need for organ transplants are increasing. Europe is experiencing a slightly better
situation. The hospitals are not under medical devices regulations as long as they produce them using
standardized biomaterials and the surgeons are supportive about 3D printers, patient-specific implants
production and medical staff technological training through their hospitals. Based on that, investing their
resources and facilities into Point-of-Care 3D Printing can contribute to the growth of the market in the
upcoming years.

While the need for an on-site 3D printed medical implants production is increasing, here comes the
challenge. Medical devices produced by 3D printing technology are classified into Class I, II or III. There
are currently two well-known models of point-of-care manufacturing. First one assumes agreement
between, responsible for the whole operation process, 3D manufacturer and the hospital, which is
outsourcing the production. The second one, makes the hospital or other medical provider a
manufacturer, which should provide all dedicated facilities. In that case, having the whole procedure
in-house would make the process time and cost-efficient.

However, the point-of-care 3D printed implants also need the preclinical testing, quality monitoring, and
expertise safety evaluation before being used. While the method is not commonly applied yet,
implementing Point-Of-Care 3D Printing may appear to you more time-consuming and relatively
expensive.

Fusedbone can be an answer to a need from an industry which has been experiencing a lot of changes
with technology. The company was born with one main goal, to provide high-quality yet affordable
patient-specific medical implants to patients all around the world. We bring a plug & play approach
for every hospital and care center that wants to start a 3D printing lab, provide custom-made medical
devices and guide you through every step from manufacturing to documentation. Let us save 62
minutes of your time per one case and deliver a medical device in 24 hours.

If you have any questions regarding our quality control process, design process and production method,
please contact us using the form below or schedule a demo . We will get back to you as soon as possible!